Aprea Therapeutics

Contributing Author

Recent Articles by Aprea Therapeutics

Aug-28	Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference APRE GlobeNewswire
Aug-12	Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update APRE GlobeNewswire
Jun-25	Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center APRE GlobeNewswire
May-14	Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update APRE GlobeNewswire